Fieldpoint Private Securities’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-60
Closed -$1K 1752
2022
Q1
$1K Buy
+60
New +$1.22K ﹤0.01% 1635

Other funds holding CDMO

Fieldpoint Private Securities's CDMO Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 60 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in CDMO in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

  • Fieldpoint Private Securities reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 60 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Fieldpoint Private Securities's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.